Skip to main content
. 2022 Sep 14;13:5401. doi: 10.1038/s41467-022-33143-w

Fig. 1. FLT3 expression by subtype in B-ALL patients of diverse ancestries.

Fig. 1

a FLT3 expression across different B-ALL subtypes in the US cohort of 1988 children and adults (Cohort 1), with the highest expression of FLT3 in ZNF384-r (ZNF384-rearrangement) ALL (n = 1988). b FLT3 expression in ALL cases (n = 49) with various ZNF384 fusions in cohort 1. Subgroups were defined by fusion partners of ZNF384. Other: fusion partners include ARID1B, CLTC, CREBBP, EWSR1, NIPBL, and SMARCA2. c FLT3 expression across different B-ALL subtypes in cohort 2 (n = 377), with the highest expression of FLT3 in ZNF384-r ALL. d FLT3 expression across ZNF384 fusions (n = 17) in the Asian cohort (Cohort 2). Subgroups were defined by fusion partners of ZNF384. Other: fusion partners include USP25 and CREBBP. e FLT3 mutations in ZNF383-r ALL from each ALL cohort. A.U. arbitrary units. Center lines indicate median values of FLT3 expression. Source data are provided as a Source Data file.